William Steere - Zoetis Independent Director

ZTS -- USA Stock  

USD 124.49  1.25  1.01%

  Director
Mr. William C. Steere, Jr. is Independent Director of the Company. Mr. Steere joined Pfizer in 1959 and held various positions, including Chief Executive Officer from 1991 until 2000, Chairman of the board of directors from 1992 until 2001, and member of the board of directors until 2011. Mr. Steere also served on the boards of Dow Jones Company, Inc. until 2007 MetLife, Inc. until 2010 and Health Management Associates, Inc. until 2014. Mr. Steeres business and senior management experience, his public company board experience and his knowledge of the animal health business obtained through his service with Pfizer make him a valuable member of our Board.
Age: 81  Director Since 2013      
973-822-7000  http://www.zoetis.com

Management Efficiency

The company has Return on Asset of 12.56 % which means that on every $100 spent on asset it made $12.56 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 62.6 % implying that it generated $62.6 on every 100 dollars invested.
The company has 6.65B in debt with debt to equity (D/E) ratio of 275.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Zoetis has Current Ratio of 4.09 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Jacqualyn FousePerrigo Company plc
2012
Bonnie BasslerRegeneron Pharmaceuticals
2016
Geoffery MerszeiOrigin Agritech Limited
2016
Joseph GoldsteinRegeneron Pharmaceuticals
1991
Michael BrownRegeneron Pharmaceuticals
1991
Larry CordellOrigin Agritech Limited
2012
Arthur RyanRegeneron Pharmaceuticals
2003
Bharat DoshiDr Reddys Laboratories Ltd
2016
Adriana KaraboutisPerrigo Company plc
2017
David GreenwayVertex Pharmaceuticals Incorpor
2017
Gary CohenPerrigo Company plc
2009
Leo PuriDr Reddys Laboratories Ltd
2018
Shikha SharmaDr Reddys Laboratories Ltd
2019
James KangOrigin Agritech Limited
2010
Jeffrey SmithPerrigo Company plc
2017
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Bruce SachsVertex Pharmaceuticals Incorpor
2017
Rolf ClassonPerrigo Company plc
2017
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Alan GarberVertex Pharmaceuticals Incorpor
2017
Allan ObermanDr Reddys Laboratories Ltd
2019

Entity Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people.

Zoetis Leadership Team

Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy
William Steere, Independent Director
Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications
Linda Rhodes, Independent Director
Frank DAmelio, Independent Director
Robert Scully, Independent Director
Clinton Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics
Stefan Weiskopf, Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand
Sanjay Khosla, Independent Director
Paul Herendeen, CFO and Executive VP
Catherine Knupp, Executive Vice President, President - Research and Development
Michael McCallister, Non-Executive Independent Chairman of the Board
Paul Bisaro, Independent Director
Alejandro Bernal, Executive Vice President and Area President of the Europe, Africa and Middle East region
Willie Reed, Independent Director
Joyce Lee, Executive Vice President and Area President of the Canada and Latin America region
Glenn David, Chief Financial Officer, Executive Vice President
Sandra Beaty, Executive Vice President - Corporate Affairs
William Doyle, Director
Andrew Fenton, Executive Vice President and Chief Digital and Technology Officer
Gregory Norden, Independent Director
Louise Parent, Independent Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Juan Alaix, Chief Executive Officer, Director

Stock Performance Indicators

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Also Currentnly Active

Purchased few shares of
few hours ago
Traded for 188.14
Purchased a lot of shares of
few hours ago
Traded for 150.35
Purchased few shares of
few hours ago
Traded for 175.29
See also Your Current Watchlist. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Search macroaxis.com